Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
10:25:31 EDT Thu 09 May 2024
Enter Symbol
or Name
USA
CA



Q:SRDX - SURMODICS INC - http://www.surmodics.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
SRDX - Q0.131.84·32.461.232.37+0.782.53.91194831.48  32.37  31.4839.41  16.7910:07:38May 0115 min RT 2¢

Recent Trades - Last 10 of 48
Time ETExPriceChangeVolume
10:07:38Q32.400.8110
10:07:38Q32.400.8110
10:07:38Q32.400.8125
10:05:42Q32.370.78100
10:03:32Q31.9950.40531
10:01:18Q32.030.44100
10:01:18Q32.030.4474
10:01:18Q32.030.44100
10:01:18Q32.030.445
10:01:18Q32.030.445

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2024-05-01 07:00U:SRDXNews ReleaseSurmodics Reports Second Quarter of Fiscal Year 2024 Financial Results; Updates Fiscal Year 2024 Financial Guidance
2024-04-19 07:00U:SRDXNews ReleaseSurmodics to Report Second Quarter of Fiscal 2024 Financial Results on May 1
2024-02-27 08:00U:SRDXNews ReleaseSurmodics to Participate in Upcoming Investor Conferences in March and April
2024-02-01 07:00U:SRDXNews ReleaseSurmodics Reports First Quarter of Fiscal Year 2024 Financial Results; Updates Fiscal Year 2024 Financial Guidance
2024-01-22 07:30U:SRDXNews ReleaseSurmodics Announces Successful Early Clinical Use of Pounce ¢ „ ¢ LP (Low Profile) Thrombectomy System, Designed to Address a Critical, Unmet Need by Facilitating Removal of Thrombi and Emboli Below the Knee
2024-01-16 07:30U:SRDXNews ReleaseSurmodics to Host Virtual Annual Meeting of Shareholders
2024-01-16 07:30U:SRDXNews ReleaseSurmodics to Report First Quarter of Fiscal 2024 Financial Results on February 1
2023-11-16 07:30U:SRDXNews ReleaseSurmodics Announces 24-Month Data from the SWING Trial Presented at VEITHsymposium
2023-11-16 07:30U:SRDXNews ReleaseSurmodics Announces TRANSCEND Trial 36-Month Data Presented at 50th Annual VEITH Symposium
2023-11-14 16:05U:SRDXNews ReleaseSurmodics to Participate in the Piper Sandler Healthcare Conference on November 28
2023-11-08 07:30U:SRDXNews ReleaseSurmodics Reports Fourth Quarter and Fiscal Year 2023 Financial Results; Introduces Fiscal Year 2024 Financial Guidance
2023-11-07 07:30U:SRDXNews ReleaseSurmodics Announces SWING Trial 24-Month Data to be Presented at VEITH Symposium on November 15
2023-11-07 07:30U:SRDXNews ReleaseSurmodics Announces TRANSCEND Trial 36-Month Data to be Presented at 50th Annual VEITH Symposium
2023-10-31 07:30U:SRDXNews ReleaseSurmodics Announces Launch of Preside ¢ „ ¢ Medical Device Coating Technology, Providing Industry-Leading Lubricity and Durability to a Broader Range of Complex Device Applications
2023-10-10 07:30U:SRDXNews ReleaseSurmodics to Report Fourth Quarter and Fiscal 2023 Financial Results on November 8
2023-08-09 17:05U:SRDXNews ReleaseSurmodics to Participate in Upcoming Investor Conferences in August
2023-08-02 07:31U:SRDXNews ReleaseSurmodics Reports Third Quarter of Fiscal Year 2023 Financial Results; Updates Fiscal Year 2023 Financial Guidance
2023-07-12 07:30U:SRDXNews ReleaseSurmodics to Report Third Quarter of Fiscal 2023 Financial Results on August 2
2023-06-20 06:30U:SRDXNews ReleaseSurmodics Receives FDA Approval for the SurVeil ¢ „ ¢ Drug-Coated Balloon
2023-06-14 07:30U:SRDXNews ReleaseSurmodics Receives FDA 510(k) Clearance for Pounce ¢ „ ¢ LP Thrombectomy System